Implantica AG (FRA:8IM1)

Implantica AG Statistics

Total Valuation

Implantica AG has a market cap or net worth of EUR 1.51 billion. The enterprise value is 1.46 billion.

Market Cap	1.51B
Enterprise Value	1.46B

Important Dates

The last earnings date was Friday, May 22, 2026.

Earnings Date	May 22, 2026
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	n/a
Shares Outstanding	n/a
Shares Change (YoY)	+0.05%
Shares Change (QoQ)	+0.01%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	7.60M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	690.03
PB Ratio	19.06
P/TBV Ratio	30.76
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-68.92
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-92.76

Financial Position

The company has a current ratio of 16.61, with a Debt / Equity ratio of 0.00.

Current Ratio	16.61
Quick Ratio	16.52
Debt / Equity	0.00
Debt / EBITDA	n/a
Debt / FCF	-0.01
Interest Coverage	-64.36

Financial Efficiency

Return on equity (ROE) is -24.29% and return on invested capital (ROIC) is -14.32%.

Return on Equity (ROE)	-24.29%
Return on Assets (ROA)	-13.87%
Return on Invested Capital (ROIC)	-14.32%
Return on Capital Employed (ROCE)	-25.42%
Weighted Average Cost of Capital (WACC)	n/a
Revenue Per Employee	47,500
Profits Per Employee	-460,435
Employee Count	50
Asset Turnover	0.02
Inventory Turnover	11.30

Taxes

In the past 12 months, Implantica AG has paid 31,000 in taxes.

Income Tax	31,000
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +42.55% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+42.55%
50-Day Moving Average	4.37
200-Day Moving Average	4.83
Relative Strength Index (RSI)	62.27
Average Volume (20 Days)	n/a

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Implantica AG had revenue of EUR 2.19 million and -21.18 million in losses. Loss per share was -0.07.

Revenue	2.19M
Gross Profit	-471,000
Operating Income	-20.21M
Pretax Income	-21.30M
Net Income	-21.18M
EBITDA	-20.17M
EBIT	-20.21M
Loss Per Share	-0.07

Balance Sheet

The company has 45.52 million in cash and 214,000 in debt, with a net cash position of 45.31 million.

Cash & Cash Equivalents	45.52M
Total Debt	214,000
Net Cash	45.31M
Net Cash Per Share	n/a
Equity (Book Value)	79.08M
Book Value Per Share	0.29
Working Capital	45.75M

Cash Flow

In the last 12 months, operating cash flow was -15.70 million and capital expenditures -39,000, giving a free cash flow of -15.74 million.

Operating Cash Flow	-15.70M
Capital Expenditures	-39,000
Depreciation & Amortization	36,000
Net Borrowing	-134,000
Free Cash Flow	-15.74M
FCF Per Share	n/a

Margins

Gross Margin	-21.56%
Operating Margin	-924.85%
Pretax Margin	-974.83%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Implantica AG does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-0.05%
Shareholder Yield	-0.05%
Earnings Yield	-1.40%
FCF Yield	-1.04%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Implantica AG has an Altman Z-Score of 227.89 and a Piotroski F-Score of 3.

Altman Z-Score	227.89
Piotroski F-Score	3